Almeida Z, Penalver M,\u00a0Mendez LE.\u00a0<\/b>\u201c<\/b>Cervical Cancer\u201d in\u00a0Clinical Gynecology<\/i>. Bieber E, Sanfilippo S, HorowitzI. eds. Churchill Livingstone Philadelphia 2006.<\/li>\n<\/ol>\nLambrou N,\u00a0Mendez LE<\/b>, Penalver M. \u201cSurgical management of recurrent endometrial carcinoma\u201d. In\u00a0Cancer of the Uterus<\/i>. Coukos G, Rubin S eds. Marcel Dekker New York 2005.<\/p>\n\n- Salom E\u00a0\u00a0<\/b>and\u00a0Mendez<\/b>\u00a0LE<\/b>. \u201cThe role of chemoprotectors during chemotherapy for gynecologic neoplasms\u201d. In\u00a0Chemotherapy<\/i>\u00a0for Gynecological Neoplasms:\u00a0 Current Therapy and Novel Approaches (Basic and Clinical Oncology Series Volume 28).<\/i>\u00a0Angioli R, Panici P, Kavanaugh J, Penalver M and Pecorelli S eds. Marcel Dekker\u00a0New York 2004.<\/li>\n
- Mendez LE\u00a0<\/b>and Penalver M. \u201cSurgical reconstruction of the pelvis in gynecologic cancer patients\u201d. In\u00a0TeLinde\u2019s Operative Gynecology.<\/i>\u00a09th<\/sup>\u00a0ed. Rock J and Thompson J eds. Lippincott, Philadelphia, PA 2003.<\/li>\n
- Mendez LE<\/b>. \u201cIatrogenic injuries in gynecologic cancer surgery.\u201d In\u00a0Surgical Clinics of North America.\u00a0<\/i>Angioli R, Mendez LE and Penalver M. eds. 81(4):897-923, 2001.<\/li>\n
- Estape R,\u00a0Mendez LE<\/b>,\u00a0 Angioli R, Penalver M. \u201cUrinary Diversion in Gynecologic Oncology.\u201d In\u00a0Surgical Clinics of North America.\u00a0<\/i>Angioli R, Mendez LE and Penalver M. eds. 81(4):781-797, 2001.<\/li>\n<\/ol>\n
Peer-reviewed articles<\/h2>\n\n- Alvarez EZ, Wolfson AH, Pearson JM, Crisp MP,\u00a0Mendez LE<\/b>, Lambrou NC, Lucci JA. A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer.\u00a0Gynecol Oncol\u00a0<\/i>2009 May;113(2):195-9. Epub 2009 Feb 28.<\/li>\n
- Castle PE, Aftab A, Saint-Jean G,\u00a0Mendez LE<\/b>. Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device. J Clin Microbiol<\/i>. 2006 Jun; 44(6):2158-9.<\/li>\n
- Leboeuf L,\u00a0Mendez LE<\/b>, Gousse AE. Small bowel obstruction associated with tension-free vaginal tape.\u00a0Urology<\/i>\u00a02004 Jun;63(6):1182-4.<\/li>\n
- Salom E,\u00a0Mendez LE<\/b>, Schey D, Lambrou N, Noor K, Gomez-Marin, O, Averette H, Penalver, M. Continent ileocolonic reservoir urinar reservoir (Miami Pouch): The University of Miami experience over 15 years.\u00a0Am J Obstet Gynecol<\/i>\u00a02004; 190: 994-1003.<\/li>\n
- Salom EM, Schey D, Penalver M, Gomez-Marin O, Lambrou N, Almeida Z,\u00a0Mendez L<\/b>. The safety of incidental appendectomy at the time of abdominal hysterectomy.\u00a0Am J Obstet Gynecol<\/i>\u00a02003 Dec; 189(6): 1563-7; discussion 1567-8.<\/li>\n
- Angioli R, Penalver M, Muzii L,\u00a0Mendez L<\/b>, Mirhashemi R, Bellati F, Croce C, Panici PB.<\/li>\n<\/ol>\n
Guidelines of how to manage vesicovaginal fistula.\u00a0Crit Rev Oncol Hematol<\/i>\u00a02003 Dec; 48(3): 295-304.<\/p>\n\n- Angioli R, Panici PB, Mirhashemi R,\u00a0Mendez L<\/b>, Cantuaria G, Basile S, Penalver M. Continent urinary diversion and low colorectal anastomosis after pelvic exenteration. Quality of life and complication risk.\u00a0Crit Rev Oncol Hematol<\/i>\u00a02003 Dec; 48(3): 281-5.<\/li>\n
- Mendez LE<\/b>, Mueller A, Salom E, Gonzalez-Quintero VH. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer.\u00a0Obstet Gynecol<\/i>\u00a02003 Nov; 102(5 Pt 2): 1200-2.<\/li>\n
- Mirhashemi R, Averette H, Lambrou N, Penalver M,\u00a0Mendez L,<\/b>\u00a0Ghurani G, Salom E. Vaginal reconstruction at the time of pelvic exenteration: A surgical and psychosexual analysis of techniques.\u00a0Gynecol Oncol<\/i>\u00a02002; 87:39-45.<\/li>\n
- Mendez LE<\/b>, Manci N, Cantuaria G, Penalver M, Averette H, Gomez-Marin O, Braunschweiger P and Nadji M. Glucose transporter-1 (GLUT 1) expression in cervical cancer and its precursors\u00a0Gynecol Oncol<\/i>\u00a02002;86: 138-143.<\/li>\n
- Mendez LE<\/b>, McCreath W, Penalver M and Angioli R. Radical vaginal trachelectomy after supracervical hysterectomy.\u00a0Gynecol Oncol\u00a0\u00a0<\/i>2002;85(3): 545-7.<\/li>\n
- Mirhashemi R, Averette H, Estape R, Angioli R, Mahran R,\u00a0Mendez L,<\/b>\u00a0Cantuaria G, Penalver\u00a0\u00a0 M. Low colorectal anastomosis following radical pelvic surgery: A risk factor analysis.\u00a0Am J Obstet Gynecol<\/i>\u00a0 2000;183(6)Dec: 1375-1380.<\/li>\n
- Mendez LE,\u00a0<\/b>Echt L, Rock J, Horowitz IR. Pulmonary endometriosis: A clinical review.\u00a0J Pelvic Surg\u00a0\u00a0<\/i>2000;6(3) May\/June: 130-135.<\/li>\n
- Mendez LE<\/b>, Majmudar B, Horowitz IR. Atypical presentation of microscopically advanced ovarian carcinoma.\u00a0South Med J\u00a0\u00a0<\/i>2000;93(3): 321-322.<\/li>\n
- Cantuaria G, Magalhaes A, Angioli R,\u00a0Mendez L<\/b>, Mirhashemi R, Wang J, Wang P, Penalver M,\u00a0 Averette H and Braunschweiger P. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma.\u00a0Cancer<\/i>\u00a02000;88(2): 381-388.<\/li>\n
- Angioli R, Estape R, Salom E, Cantuaria G, Mirhashemi R,\u00a0Mendez L,\u00a0<\/b>Yoo R and Penalver M. Radical hysterectomy for cervical cancer: Hysterectomy before pelvic lymphadenectomy or vice versa?\u00a0Int J Gynecol Cancer\u00a0<\/i>1999;9: 307-311.<\/li>\n
- Mendez LE,<\/b>\u00a0Joy S, Angioli R, Estape R and Penalver M. Primary uterine angiosarcoma.\u00a0\u00a0Gynecol Oncol\u00a0<\/i>1999;75: 272-276.<\/li>\n
- Mendez LE,\u00a0<\/b>Cantuaria G, Angioli R, Mirhashemi R, Gabriel C, Estape R and Penalver M. Evaluation of the Pfannenstiel incision for radical hysterectomy with pelvic and paraaortic lymphadenectomy.\u00a0Int J Gynecol Cancer\u00a0<\/i>1999;9: 418-420.<\/li>\n
- Mendez LE<\/b>, Bhoola S, Horowitz IR. Bilateral tubo-ovarian abscesses four years after total abdominal hysterectomy.\u00a0Infect Dis Obstet Gynecol<\/i>\u00a01998; 6:138-140.<\/li>\n
- Mekki Y, Gilles J,\u00a0Mendez LE<\/b>, O\u2019Sullivan MJ. Abdominal pregnancy: to remove or not to\u00a0\u00a0 remove the placenta.\u00a0Prim\u00a0 Care Update Ob Gyns<\/i>\u00a01998 Jul 1;5(4):192.<\/li>\n
- Mendez LE<\/b>, Medina C. Late complication of laparoscopic salpingoophorectomy: retained foreign body presenting as an acute abdomen.\u00a0J\u00a0 Soc Laparoendoscopic Surg\u00a0<\/i>1997; 1:77-79.<\/li>\n
- Saint-Louis H,\u00a0Mendez\u00a0<\/i>LE<\/b>, Penalver M. Managing the gynecologic causes of severe abdominal pain. J of Critical Illness<\/i>\u00a01996; 11:793-800.<\/li>\n
- Colsky AS,\u00a0Mendez LE<\/b>, Peacock JS. FcR-Independent antibody-mediated cellular cytotoxicity.\u00a0J Leuk Biol\u00a0<\/i>1991; 49:548-555.<\/li>\n<\/ol>\n
Other publications and published abstracts<\/h2>\n\n- Salom E Jr, Schey D, Kassira N, Gomez O,\u00a0Mendez L<\/b>, Jhamb N, Lambrou N, Lucci III J, Penalver M. \u201cA comparison of continent and incontinent urinary diversion after pelvic exenterations: A study of long term morbidity and renal function.\u201d\u00a0Gynecol Oncol<\/i>\u00a02005; 96 (3): 921 [Abstract].<\/li>\n
- Almeida Z, Jhamb N, Rodriguez L, Gomez O, Nguyen T, Hus N, Salom E, Lucci III J, Penalver M,\u00a0Mendez L.<\/b>\u00a0\u201cCervical cancer stage IBI:\u00a0 A comparison between tumor sizes < 2cm Vs.\u00a0 > 2cm and < 4cm\u201d.\u00a0Gynecol Oncol<\/i>\u00a02005; 96 (3): 920 [Abstract].<\/li>\n
- Almeida Z,\u00a0Mendez LE,\u00a0<\/b>Gomez O, Jhamb N, Ghurani G, Lambrou N, Salom E, Hlavin P, Penalver M.\u00a0<\/b>\u201cThe effect of music therapy and guided imagery on postoperative pain, anxiety and medication use: a prospective, randomized trial\u201d.\u00a0J Pelvic Med Pelvic Surg<\/i>\u00a02003;9 (suppl 1):S27. [Abstract]<\/li>\n
- Almeida Z,\u00a0Mendez L<\/b>, Gomez O, Jhamb N, Ghurani G, Lambrou N, Salom E, Hlavin\u00a0\u00a0 P, Penalver M.\u00a0 \u201cThe Effect of Music Therapy and Guided Imagery on Postoperative Pain, Anxiety and Medication Use: A Prospective Randomized Study\u201d.\u00a0Gynecol Oncol\u00a0<\/i>2003; 88 (2): 198 [Abstract].<\/li>\n
- Salom E,\u00a0Mendez L<\/b>, Lambrou N, Kamat, G\u00f3mez-Mar\u00edn O, Ghurani G, Mirhashemi R, Almeida Z, Penalver M, Averette H. Bulky stage IB2 cervical cancer: Feasibility and survival with surgical management vs radiation alone\u00a0J Pelvic Med Pelvic Surg<\/i>\u00a02003;9(suppl 1):S27. [Abstract]<\/li>\n
- Salom E,\u00a0Mendez L<\/b>, Jhamb N, Lambrou N, Almeida Z, Mirhashemi R, Ghurani G, Averette H, Penalver M. Endometrial cancer in women younger than 40 years of age: a clinicopathologic review\u00a0J Pelvic Med Pelvic Surg<\/i>\u00a02003;9(suppl 1):S26. [Abstract].<\/li>\n
- Salom E, Schey D, Gomez-Marin O,\u00a0Mendez L<\/b>, Lambrou N., Almeida Z, Penalver M.\u00a0 Incidental appendectomy at the time of gynecologic procedures: A case-controlled study.\u00a0J Pelvic Med Pelvic Surg<\/i>\u00a02003;9(suppl 1):S1. [Abstract]<\/li>\n
- \u00a0Lambrou N, Mirhashemi R, Beach H,\u00a0Mendez LE<\/b>, Ghurani G, Salom E, Almeida Z, Penalver M. \u201cOptimal surgical cytoreduction in patients with stage III\/IV endometrial carcinoma: a study of morbidity and survival\u201d.\u00a0Gynecol Oncol<\/i>\u00a02003;88:203. [Abstract]<\/li>\n
- Penalver M,\u00a0Mendez LE<\/b>, Lambrou N. What\u2019s new in obstetrics and gynecology. J Am Coll Surg\u00a0<\/i>\u00a02002 Aug;195(2):203-7.<\/li>\n
- Estape R, Angioli R,\u00a0Mendez LE<\/b>, Nieves W, Ghurani G, Lambrou N and Penalver M. 3-Day\u00a0\u00a0\u00a0\u00a0 Topotecan and Carboplatin in first line treatment of ovarian cancer. A Phase II trial.\u00a037th Annual American Society of Clinical Oncology<\/i>\u00a0(ASCO), San Francisco, CA. May 12-15, 2001. [Abstract]<\/li>\n
- \u00a0Mendez LE,\u00a0<\/b>Gebka A, Feun LG. The role of intraperitoneal chemotherapy in epithelial ovarian cancer.\u00a0Contemporary OB\/GYN\u00a0<\/i>\u00a045(6): 29-43, 2000.<\/li>\n
- Whitted W, Verma U, Vogl B,\u00a0Mendez L.<\/b>\u00a0Does Cesarean section increase the prevalence of adenomyosis: A retrospective review.\u00a0Obstet Gynecol\u00a0<\/i>2000 Apr 1:95 (4 Suppl 1):S83 [Abstract].<\/li>\n
- Mendez LE<\/b>, Santanam N, Parthasarathy S, Horowitz IR. Autoantibodies to lipid peroxide-modified proteins in patients with gynecologic malignancies.\u00a0Gynecol Oncol<\/i>\u00a072 (3): 503, 1999 [Abstract].<\/li>\n
- Estape R, Moffett DH, Angioli R, Cantuaria G, Mirhashemi R,\u00a0Mendez L<\/b>, Penalver M. Hysterectomy versus conservative management of recurrent cervical dysplasia: A cost-benefit analysis.\u00a0Gynecol Oncol<\/i>\u00a072(3): 498, 1999. [Abstract]<\/li>\n
- Estape R, Angioli R,\u00a0Mendez L<\/b>, Cantuaria G, Mirhashemi R, Hunt M, Penalver M. 3-day bleomycin, etoposide and platinum (BEP) for ovarian germ cell tumors.\u00a0Gynecol Oncol<\/i>\u00a072(3): 497, 1999. [Abstract]<\/li>\n
- Estape R, Milian N, Angioli R, Cantuaria G, Mirhashemi R,\u00a0Mendez L<\/b>, Penalver M. Incompletely staged germ cell tumors: Is staging necessary?\u00a0Gynecol Oncol<\/i>\u00a072(3): 497, 1999.[Abstract]<\/li>\n
- Cantuaria G, Angioli R, Mirhashemi R,\u00a0Mendez L<\/b>, Estape R, Penalver M. Primary malignant melanoma of the uterine cervix: A case report and review of the literature.\u00a0Gynecol Oncol<\/i>\u00a072(3): 492-93, 1999. [Abstract]<\/li>\n
- Colsky AS,\u00a0Mendez LE<\/b>, Peacock JS. Target cell internalization by macrophages induced by surrogate adhesion receptors. Advances in Gene Technology: The Molecular Biology of Immune Disease and The Immune Response, Proceedings of the Miami Bio\/Technology Winter Symposia\u00a0<\/i>1990, p. 132.<\/i><\/li>\n<\/ol>\n
PROFESSIONAL \u00a0 Funded research\u00a0\u00a0<\/i><\/p>\n
\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1. \u00a0\u00a0\u00a0\u00a0\u00a0 A phase II trial of Consolidation Taxotere in patients with optimally debulked stage IC to IV<\/p>\n
\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0epithelial ovarian or primary peritoneal carcinoma. Role, P.I., 2003-04, Funding Aventis<\/p>\n
\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Oncology, $350,000.<\/p>\n
\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0 \u00a0\u00a0\u00a02.\u00a0\u00a0\u00a0\u00a0 A Randomized Phase III Trial of Gemzar versus Doxil with Crossover Treatment Option for<\/p>\n
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Patients with \u00a0Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer<\/p>\n
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Undergoing Second or Third- Line Chemotherapy. Role, P.I. 2003-04, Funding Eli Lilly, $50,000<\/p>\n
\u00a03.\u00a0\u00a0\u00a0\u00a0 Phase I, Fixed-Dose Rate Gemcitabine + Carboplatin in Platinum-Sensitive, Late-Relapsed Ovarian Cancer, Fallopian Tube or Primary Peritoneal Cancer. Role, P.I. 2003-04, Funding Eli Lilly, $50,000 \u00a0 4.\u00a0\u00a0\u00a0\u00a0 A Phase I\/II Evaluation of a Self-Sampling Device for Combined Cericovaginal Cytology and Sexually Transmitted Diseases (STD). Role, P.I. Start date 2003-04, Funding Bay Point Group, $50,000. \u00a0 5.\u00a0\u00a0\u00a0\u00a0 A phase II study of ET-743 as second-line therapy in subjects with persistent or recurrent endometrial cancer. Role, P.I. 2003-04, Funding Johnson and Johnson, $16,000 per patient. \u00a0 6.\u00a0\u00a0\u00a0\u00a0 A phase I\/II study of docetaxel as a radiosensitizer for locally advanced cevical cancer. Role, P.I. 2003-04. Funding Aventis Oncology, $210,000. \u00a0 7.\u00a0\u00a0\u00a0\u00a0 Surrogate receptor mediated cellular cytotoxicity.\u00a0<\/i>University of Miami School of Medicine, Dept. of Microbiology and Immunology. Mentor: James Peacock, Ph.D. June-August 1987. Funding: American Cancer Society Summer internship grant.<\/p>\nEditorial\u00a0 responsibilties<\/h2>\n
1.\u00a0\u00a0\u00a0\u00a0 Angioli R,\u00a0Mendez LE<\/b>\u00a0and Penalver M. Editors, Gynecologic Oncology,\u00a0Surgical Clinics of North America<\/i>, WB Saunders, vol 81(4): 2001.<\/p>\nPositions held<\/h2>\n\n- Membership committee, Society of Gynecologic Oncologists, 2010-<\/li>\n
- National proctor, DaVinci robotic platform, Intuitive Surgical, 2009-<\/li>\n
- National proctor, Ethicon Endosurgery, Advanced GYN laparoscopy, 2008-<\/li>\n
- National proctor, Boston Scientific, Advanced pelvic surgery, 2007-<\/li>\n
- Reviewer,\u00a0Gynecologic Oncology\u00a0<\/i>journal, 2003-<\/li>\n
- Reviewer,\u00a0Obstetrics and Gynecology\u00a0<\/i>journal, 2002-\n
\n- MercyHospital Robotics Committee, 2009- , Chairman 2009-<\/li>\n
- MercyHospital Cancer Committee, 2006- , Chairman 2008-<\/li>\n
- Baptist Health Doctors Hospital Credentials Committee, 2008-<\/li>\n
- University of Miami Faculty Senate, Alternate Senator, 2002-2004<\/li>\n
- Honors Program in Medical Education Committee, University of Miami School of Medicine, 2001-2004<\/li>\n
- University of Miami\/Sylvester Cancer Center Ethics Committee, 2003-2004<\/li>\n
- University of Miami Data Monitoring and Safety Committee, 2003-2004<\/li>\n
- Co-PI, Gynecologic Oncology Group (GOG), University of\u00a0 Miami, 2003-2004<\/li>\n
- Co-Chair, Gynecologic Oncology Site Disease Group,SylvesterCancerCenter, 2003\n
\n- University of Miami\/Jackson Memorial Medical Center, Tissue Committee, 2002-2004<\/li>\n
- University of Miami\/Jackson Memorial Medical Center, SylvesterCancerCenter, Tumor Registry Cancer Committee, 2002-2004<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n
Professional memberships<\/h2>\n\n- Full Member, International Gynecologic Cancer Society (IGCS), 2010-<\/li>\n
- Fellow, Society of Gynecologic Oncologists (SGO), 2004-<\/li>\n
- Fellow, AmericanCollege of Surgeons (ACS), 2005-<\/li>\n
- Fellow, AmericanCollege of Obstetricians and Gynecologists (ACOG), 2002-<\/li>\n
- Full member, Florida Society of Gynecologic Oncologists (FSGO), 2002-<\/li>\n
- Active member, American Association for Cancer Research (AACR), 2002-<\/li>\n
- William A. Little Obstetrical and Gynecological Society, 1997-<\/li>\n<\/ul>\n
Honors\/Awards<\/h2>\n
![](\"https:\/\/www.toplinemd.com\/south-florida-gynecologic-oncology\/wp-content\/uploads\/sites\/285\/2023\/09\/Luis-E-Mendez.jpg\" "\\"Luis-E-Mendez\\"")
<\/span><\/div><\/div><\/div>